First Duchenne’s Muscular Dystrophy Patient To Receive Umbilical Cord Stem Cell Therapy In US Turns 30

The first patient with Duchenne Muscular Dystrophy to be granted FDA approval for allogeneic adult stem cell therapy in the United States turned 30 this year, well surpassing his original life expectancy and paving the way for future patients, according to non-profit organization Coming Together For A Cure. WICHITA, KANSAS (PRWEB) MAY 18, 2016 - [...]

First Duchenne’s Muscular Dystrophy Patient To Receive Umbilical Cord Stem Cell Therapy In US Turns 302021-03-01T12:32:49-06:00

Why Stem Cells Work: Clinical Trials for Spinal Cord Injury, Multiple Sclerosis, Rheumatoid Arthritis, and Duchenne’s Muscular Dystrophy

Dr. Riordan discusses: How our lab selects uses specialized screening techniques to select only the stem cells that we know will be the most useful for our patients. Only about 1 in 100 cords pass this screening process. How umbilical cord mesenchymal stem cells (MSC) control inflammation, modulate the immune system [...]

Why Stem Cells Work: Clinical Trials for Spinal Cord Injury, Multiple Sclerosis, Rheumatoid Arthritis, and Duchenne’s Muscular Dystrophy2021-03-01T13:32:02-06:00

READ DR RIORDAN’S BOOK

Want to learn more about how stem cell therapy is disrupting medicine and transforming lives?

Purchase a copy of Dr. Riordan’s Amazon #1 bestselling book about stem cell therapy today!

Purchase
Go to Top